European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G. van der Heijden(Radboud University Nijmegen), Michael Rink(Marienkrankenhaus Hamburg), Laura S. Mertens(Oncode Institute), Y. Neuzillet(Université de Versailles Saint-Quentin-en-Yvelines), Valeria Panebianco(Sapienza University of Rome), Albert Carrión(Universitat Autònoma de Barcelona), Rainer Fietkau(Friedrich-Alexander-Universität Erlangen-Nürnberg), George N. Thalmann(University Hospital of Bern), Alberto Martini(The University of Texas MD Anderson Cancer Center), Richard P. Meijer(Unknown), Anja Lorch(University Hospital of Zurich), Jason A. Efstathiou(Massachusetts General Hospital), Richard Cathomas(Kantonsspital Graubünden), Éva Compérat(Vienna General Hospital), Matthew I. Milowsky(UNC Lineberger Comprehensive Cancer Center), Harman Max Bruins(Zuyderland Medisch Centrum), Konstantinos Dimitropoulos(Aberdeen Royal Infirmary), Sæbjørn Sæbjørnsen(European Association of Urology), Param Mariappan(Western General Hospital), Emma Jane Smith(European Association of Urology), Mithun Kailavasan(Victoria Hospital)
Cited by 159
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility
|European Urology|2021|612
EAU Guidelines on Penile Cancer: 2014 Update
|European Urology|2014|594